WO2026133284 - METHODS OF EXPANDING AND PRODUCTION OF GAMMADELTA T CELLS
National phase entry is expected:
Publication Number
WO/2026/133284
Publication Date
25.06.2026
International Application No.
PCT/IB2025/063258
International Filing Date
19.12.2025
Title **
[English]
METHODS OF EXPANDING AND PRODUCTION OF GAMMADELTA T CELLS
[French]
MÉTHODES D'EXPANSION ET DE PRODUCTION DE LYMPHOCYTES T GAMMA-DELTA
Applicants **
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventors
BOTHUN, Alisha
GU, Gary
DONG, Tianhan
WANG, Dandan
SOBHANA, Nandhu
Priority Data
63/736,185
19.12.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3265 | |
| EPO | Filing, Examination, Granting | 27878 | |
| Japan | Filing, Examination, Granting | 3323 | |
| South Korea | Filing, Examination, Granting | 4641 | |
| USA | Filing, Examination, Granting | 12540 |
Total:
51,647
Contact Us
Abstract[English]
The present disclosure relates to expanding and production of gamma delta (γδ) T cells, e.g., Vδ1+ γδ T cells. In particular, the present disclosure provides improved methods and processes for activating and expanding γδ T cells (e.g., Vδ1+ γδ T cells) using combined CD3 and CD30 agonists and cytokines.[French]
La présente divulgation concerne l'expansion et la production de lymphocytes T gamma-delta (γδ), par exemple des lymphocytes T γδ Vδ1+. En particulier, la présente divulgation fournit des méthodes et des procédés améliorés pour activer et développer des lymphocytes T γδ (par exemple, des lymphocytes T γδ Vδ1+) en utilisant des agonistes combinés de CD3 et CD30 et des cytokines.